Nukleus Office solutions Complete Financial Statements

NUKLEUS • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022

Complete Financial Data Export

Export complete financial statements for Nukleus Office solutions (NUKLEUS). Downloads include all available records across all periods. For market performance, see the NUKLEUS stock price today .

Profitability Ratios

Net Profit Margin 6.90% 2025 data
EBITDA Margin 24.14% 2025 data
Operating Margin 23.00% 2025 data
Return on Assets 3.33% 2025 data
Return on Equity 5.13% 2025 data

Balance Sheet Ratios

Current Ratio 2.27 2025 data
Debt to Equity 1.54 2025 data
Equity Ratio 65.00% 2025 data
Asset Turnover 0.48 2025 data

Year-over-Year Growth Analysis

Comparing March 2024 vs March 2025
Revenue Growth
+70.6%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+133.3%
Year-over-Year
Expense Growth
+57.1%
Year-over-Year
Assets Growth
+215.8%
Year-over-Year
Equity Growth
+875.0%
Year-over-Year
Liabilities Growth
+215.8%
Year-over-Year
Operating Cash Flow Growth
-300.0%
Year-over-Year
Investing Cash Flow Growth
-28.6%
Year-over-Year
Financing Cash Flow Growth
+337.5%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Revenue 29 17 11 3
Expenses 22 14 10 3
EBITDA 7 3 1 0
Operating Profit Margin % 23.00% 19.00% 13.00% 5.00%
Depreciation 3 2 1 0
Interest 1 0 0 0
Profit Before Tax 3 2 1 0
Tax 1 0 0 0
Net Profit 2 1 1 0
Earnings Per Share (₹) 7.53 19.71 42.04 6.65

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022
ASSETS
Total Assets 60 19 7 3
Current Assets 34 9 3 3
Fixed Assets 10 5 2 0
Capital Work in Progress 3 2 0 0
Investments 0 0 0 0
Other Assets 46 12 5 3
LIABILITIES
Total Liabilities 60 19 7 3
Current Liabilities 15 9 5 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 39 4 1 0
Share Capital 4 3 0 0
Reserves & Surplus 35 2 1 0

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Operating Activities -8 4 1 -1
Investing Activities -9 -7 -4 -1
Financing Activities 35 8 3 2
Net Cash Flow 18 6 0 0